CD4 T helper cell subsets and related human immunological disorders

X Zhu, J Zhu - International journal of molecular sciences, 2020 - mdpi.com
The immune system plays a critical role in protecting hosts from the invasion of organisms.
CD4 T cells, as a key component of the immune system, are central in orchestrating adaptive …

Next-generation regulatory T cell therapy

LMR Ferreira, YD Muller, JA Bluestone… - Nature reviews Drug …, 2019 - nature.com
Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …

Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells

D Chauss, T Freiwald, R McGregor, B Yan, L Wang… - Nature …, 2022 - nature.com
The molecular mechanisms governing orderly shutdown and retraction of CD4+ type 1
helper T (TH1) cell responses remain poorly understood. Here we show that complement …

Complex genetic signatures in immune cells underlie autoimmunity and inform therapy

V Orrù, M Steri, C Sidore, M Marongiu, V Serra, S Olla… - Nature …, 2020 - nature.com
We report on the influence of~ 22 million variants on 731 immune cell traits in a cohort of
3,757 Sardinians. We detected 122 significant (P< 1.28× 10− 11) independent association …

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

L Zhang, X Yu, L Zheng, Y Zhang, Y Li, Q Fang, R Gao… - Nature, 2018 - nature.com
T cells are key elements of cancer immunotherapy but certain fundamental properties, such
as the development and migration of T cells within tumours, remain unknown. The enormous …

The balance of Th17 versus Treg cells in autoimmunity

GR Lee - International journal of molecular sciences, 2018 - mdpi.com
T helper type 17 (Th17) cells and pTreg cells, which share a common precursor cell (the
naïve CD4 T cell), require a common tumor growth factor (TGF)-β signal for initial …

[HTML][HTML] The principles of engineering immune cells to treat cancer

WA Lim, CH June - Cell, 2017 - cell.com
Chimeric antigen receptor (CAR) T cells have proven that engineered immune cells can
serve as a powerful new class of cancer therapeutics. Clinical experience has helped to …

Cellular networks controlling T cell persistence in adoptive cell therapy

JD Chan, J Lai, CY Slaney, A Kallies… - Nature Reviews …, 2021 - nature.com
The antitumour activity of endogenous or adoptively transferred tumour-specific T cells is
highly dependent on their differentiation status. It is now apparent that less differentiated T …

Immunopathology of multiple sclerosis

CA Dendrou, L Fugger, MA Friese - Nature Reviews Immunology, 2015 - nature.com
Two decades of clinical experience with immunomodulatory treatments for multiple sclerosis
point to distinct immunological pathways that drive disease relapses and progression. In …

B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers

J Van Langelaar, L Rijvers, J Smolders… - Frontiers in …, 2020 - frontiersin.org
Historically, multiple sclerosis (MS) has been viewed as being primarily driven by T cells.
However, the effective use of anti-CD20 treatment now also reveals an important role for B …